Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for Vertigo and Hearing Loss in Meniere's Disease
NCT04815187Phase 4Active, not recruiting
- Sponsor
- House Institute Foundation
- Start
- Jun 2021
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of montelukast in Meniere's disease (MD), sponsored by House Institute Foundation. Started Jun 2021; status: active, not recruiting.
02
Drugs
montelukast
03
Conditions
Meniere's disease (MD)
Beyond the preview
Go deeper on NCT04815187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04815187.